Ludwig D - Search Results

1

Crohn's disease and sarcoidosis: systemic granulomatosis?

Fellermann K, Stahl M, Dahlhoff K, Amthor M, Ludwig D, Stange EF. Fellermann K, et al. Among authors: ludwig d. Eur J Gastroenterol Hepatol. 1997 Nov;9(11):1121-4. doi: 10.1097/00042737-199711000-00018. Eur J Gastroenterol Hepatol. 1997. PMID: 9431906

2

Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease.

Homann N, Klarmann U, Fellermann K, Brüning A, Klingenberg-Noftz R, Witthöft T, Stange EF, Ludwig D. Homann N, et al. Among authors: ludwig d. Inflamm Bowel Dis. 2005 Feb;11(2):126-32. doi: 10.1097/00054725-200502000-00005. Inflamm Bowel Dis. 2005. PMID: 15677905

3

The postprandial portal flow is related to the severity of portal hypertension and liver cirrhosis.

Ludwig D, Schwarting K, Korbel CM, Brüning A, Schiefer B, Stange EF. Ludwig D, et al. J Hepatol. 1998 Apr;28(4):631-8. doi: 10.1016/s0168-8278(98)80287-0. J Hepatol. 1998. PMID: 9566832

4

Intestinal expression of human heat shock protein 90 in patients with Crohn's disease and ulcerative colitis.

Stahl M, Ludwig D, Fellermann K, Stange EF. Stahl M, et al. Among authors: ludwig d. Dig Dis Sci. 1998 May;43(5):1079-87. doi: 10.1023/a:1018847205420. Dig Dis Sci. 1998. PMID: 9590425

5

Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506).

Fellermann K, Ludwig D, Stahl M, David-Walek T, Stange EF. Fellermann K, et al. Among authors: ludwig d. Am J Gastroenterol. 1998 Oct;93(10):1860-6. doi: 10.1111/j.1572-0241.1998.539_g.x. Am J Gastroenterol. 1998. PMID: 9772045

6

Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease.

Woywodt A, Ludwig D, Neustock P, Kruse A, Schwarting K, Jantschek G, Kirchner H, Stange EF. Woywodt A, et al. Among authors: ludwig d. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):267-76. doi: 10.1097/00042737-199903000-00010. Eur J Gastroenterol Hepatol. 1999. PMID: 10333199

7

Enhanced intestinal expression of heat shock protein 70 in patients with inflammatory bowel diseases.

Ludwig D, Stahl M, Ibrahim ET, Wenzel BE, Drabicki D, Wecke A, Fellermann K, Stange EF. Ludwig D, et al. Dig Dis Sci. 1999 Jul;44(7):1440-7. doi: 10.1023/a:1026616221950. Dig Dis Sci. 1999. PMID: 10489932

8

Mesenteric blood flow is related to disease activity and risk of relapse in Crohn's disease: a prospective follow-up study.

Ludwig D, Wiener S, Brüning A, Schwarting K, Jantschek G, Stange EF. Ludwig D, et al. Am J Gastroenterol. 1999 Oct;94(10):2942-50. doi: 10.1111/j.1572-0241.1999.01442.x. Am J Gastroenterol. 1999. PMID: 10520849

9

Efficacy of azathioprine in the treatment of chronic active Crohn's disease: prospective one-year follow-up study. German Imurek Study Group.

Ludwig D, Stange EF. Ludwig D, et al. Z Gastroenterol. 1999 Nov;37(11):1085-91. Z Gastroenterol. 1999. PMID: 10604222 Clinical Trial.

10

Mycophenolate mofetil: lack of efficacy in chronic active inflammatory bowel disease.

Fellermann K, Steffen M, Stein J, Raedler A, Hämling J, Ludwig D, Loeschke K, Stange EF. Fellermann K, et al. Among authors: ludwig d. Aliment Pharmacol Ther. 2000 Feb;14(2):171-6. doi: 10.1046/j.1365-2036.2000.00695.x. Aliment Pharmacol Ther. 2000. PMID: 10651657 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

778 results

Search Page

Filters